Risk to Benefit Ratio: when is a drug too risky to stay on the market?

Pundits have said it takes at least 100 deaths for the FDA to act regarding pulling a prescription drug from the marketplace. The playing field is far from level for risky medications versus the risks of supplements including herbs. It is of little comfort to consumers that the FDA has no written guidelines for deciding… Continue reading Risk to Benefit Ratio: when is a drug too risky to stay on the market?

News Briefs

Sour milk politics; Congress tries to improve school lunches; court says no to Monsanto; and Harvard researchers develop Frankenstein machine.

What Your Waistline Means to Your Health

The New England Journal of Medicine in a November 2008 issue published research that had tracked nearly 360,000 men and women in 9 European countries for nearly 10 years. The results confirm research that has proliferated in the U.S. medical literature that is, a full to bursting waistline is a stronger predictor of premature death… Continue reading What Your Waistline Means to Your Health

Drugs in Our Water

Thanks to the imagination of a school girl in WV, a growing appreciation exists of our exposure to pharmaceutical drugs in our water supply system. It was her school experiment after reading about drugs in Swiss lakes that sparked the US Geological Service to launch a survey of streams, rivers, lakes, and ponds. The results… Continue reading Drugs in Our Water

The Campaign to Cover Up Americans from Sun Exposure; what are the risks versus the benefits

The Campaign to Cover Up Americans from Sun Exposure; what are the risks versus the benefits The campaign to address Americans’ sun exposure has become the standard of care in American medicine. One of this country’s leading medical educators and researchers, Michael Holick, MD, even lost his tenure ship in dermatology at Boston University when… Continue reading The Campaign to Cover Up Americans from Sun Exposure; what are the risks versus the benefits